Consensus Amgen Inc.

Equities

AMGN

US0311621009

Real-time Estimate Cboe BZX Other stock markets 10:12:07 2024-05-16 am EDT			5-day change	1st Jan Change
312.9 ^USD	-1.22%		-0.24%	+8.36%

May. 14	Transcript : Amgen Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM
May. 13	Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating	MT

Evolution of the average Target Price on Amgen Inc.

Price target over the last 5 years

History of analyst recommendation changes

3a7f43a6b757ba452e.UYcVjs2mfnlJ_Nw8-GVrYsWq8OCyJSOUmhreKh6V19k.POZn3rnXBCAwloNRyAg_WpDwspDWEm3m1VnuUGTe5oBlsmzr-8pLTAKejQ~6b3bb2f7d3a78aaa7df9e84f8aeaf002

Analyst Recommendations on Amgen Inc.

Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating	May. 13	MT
ANALYST RECOMMENDATIONS : UBER, Luluemon, Airbnb, Progressive...	May. 09
Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170	May. 09	MT
Mizuho Securities Raises Amgen's Price Target to $235 From $223	May. 08	MT
North American Morning Briefing : Stock Futures -2-	May. 06	DJ
UBS Adjusts Price Target on Amgen to $307 From $284, Maintains Neutral Rating	May. 03	MT
Deutsche Bank Adjusts Price Target on Amgen to $310 From $285, Hold Rating Maintained	May. 03	MT
William Blair Upgrades Amgen to Outperform From Market Perform	May. 03	MT
Leerink Adjusts Price Target on Amgen to $352 From $324, Keeps Market Perform Rating	May. 03	MT
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	May. 03	RE
Barclays Upgrades Amgen to Equalweight From Underweight, Adjusts Price Target to $300 From $230	May. 03	MT
Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating	May. 03	MT
RBC Adjusts Price Target on Amgen to $328 From $332, Keeps Outperform Rating	May. 03	MT
BMO Capital Adjusts Price Target on Amgen to $355 From $336, Keeps Outperform Rating	May. 03	MT
Goldman Sachs Adjusts Price Target on Amgen to $350 From $359, Keeps Buy Rating	May. 03	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating	Apr. 17	MT
TD Cowen Cuts Price Target on Amgen to $360 From $370, Buy Rating Kept	Apr. 15	MT
Goldman Sachs Adjusts Amgen Price Target to $359 From $361, Maintains Buy Rating	Apr. 15	MT
BMO Lowers Price Target on Amgen to $336 From $343	Apr. 12	MT
Morgan Stanley Cuts Price Target on Amgen to $271 From $278, Keeps Equalweight Rating	Apr. 09	MT
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
Oppenheimer Adjusts Amgen Price Target to $380 From $350, Maintains Outperform Rating	Feb. 07	MT
TD Cowen Adjusts Amgen Price Target to $370 From $336, Maintains Outperform Rating	Feb. 07	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

319 USD

Average target price

314.6 USD

Spread / Average Target

-1.38%

High Price Target

380 USD

Spread / Highest target

+19.11%

Low Price Target

170 USD

Spread / Lowest Target

-46.72%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Amgen Inc.

Redburn Atlantic
Mizuho Securities
UBS
Deutsche Bank Securities
William Blair & Co.
Leerink Partners
Barclays
Morgan Stanley
RBC Capital Markets
BMO Capital
Goldman Sachs
TD Cowen
Oppenheimer
Baird
Daiwa Securities
Truist Securities
Argus
HSBC
Jefferies & Co.
Credit Suisse
DA Davidson
Piper Sandler
Wells Fargo Securities
SVB Securities LLC
Cowen
Atlantic Equities
BofA Securities
SVB Leerink
JPMORGAN	Cory Kasimov
RBC	Kennen Mackay

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar